Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

3 years ago

Interim data from 27 patients, who had completed 3 months in the HBV002 study in chronic Hepatitis B (CHB) patients,…

Clover Signs COVID-19 Vaccine Supply Agreement with UNICEF

3 years ago

CHENGDU, China, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; Stock code: 2197.HK), a global clinical-stage biotechnology company…

Healthcare Triangle to Present at Sidoti December Virtual Microcap Conference

3 years ago

PLEASANTON, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company"), a leading provider…

Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development

3 years ago

Science 37 enhances its Operating Systems, adding ability to deploy its technology platform into China and Russia and strengthening global…

Harpoon Therapeutics to Host Pipeline Update Call and Webcast on December 13, 2021

3 years ago

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing…

Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement

3 years ago

Screening identifies several unique compound series that inhibit the SARS-CoV-2 nsp5 main protease, a validated target for the treatment of…

Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference

3 years ago

CARLSBAD, Calif. , Dec. 07, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:…

CorVel Launches New Workers’ Compensation and Liability Solution, Leveraging Artificial Intelligence and Predictive Analytics

3 years ago

CogencyIQ helps risk managers and claims professionals navigate increasingly complex claims and massive amounts of data to improve outcomes for…

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022

3 years ago

NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial…

Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe

3 years ago

Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe First round of pricing negotiations completed in the…